Recent Finacing
Recent Raise
Carisma Therapeutics develops engineered macrophage-based cell therapies that use in vivo engineering of monocytes/macrophages to create autologous CAR‑macrophages for solid tumor treatment, collaborating with academic and industry partners.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor